Complete remission at 8 weeks with high-dose adrenomedullin in UC

Complete remission at 8 weeks was observed in patients with steroid-resistant ulcerative colitis who received a high dose of adrenomedullin, according to study published in The Journal of Gastroenterology.“[Despite] the limited number of patients in this double-blind randomized trial, we observed the successful complete remission at 8 weeks in patients with steroid-resistant UC receiving a high dose of [adrenomedullin(AM)],” Toshihiro Kita, MD, from the division of circulatory and body fluid regulation, department of internal medicine, faculty of medicine at the University ofRead More